Diversity in Alzheimer's Research
A critical examination reveals the lack of diversity in Alzheimer's research, particularly affecting black Americans, which hampers our understanding of the disease. Researchers emphasize the need to include underrepresented populations in clinical trials to ensure that findings accurately reflect the experiences of those most at risk. By adjusting eligibility criteria and actively over-enrolling diverse groups, the scientific community can gain deeper insights into Alzheimer's pathology and treatment efficacy.In this clip
From this podcast
Short Wave
How Well Does A New Alzheimer's Drug Work For Those Most At Risk?
Related Questions
How does race affect scientific studies for health, and how do these studies apply to different races, such as Black and white populations, according to Andrew Huberman in the episode Improving Science & Restoring Trust in Public Health | Dr. Jay Bhattacharya and the clip Health Equity Research?
What does recent Alzheimer's research suggest?
What are recent Alzheimer's studies saying?